BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma
Background Laryngeal squamous cell carcinoma (LSCC) remains one of the most common respiratory tumors worldwide. Baculoviral inhibitor of apoptosis repeat containing 5 (BIRC5) is a member of the inhibitor-of-apoptosis protein family. BIRC5 plays an important role in various types of cell proliferati...
Main Authors: | Nan Wang, Xuanyu Huang, Jinsheng Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2022-02-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/12871.pdf |
Similar Items
-
Identification of Down-Expressed CRNN Associated with Cancer Progression and Poor Prognosis in Laryngeal Squamous Cell Carcinoma
by: Feilong Hong, et al.
Published: (2024-03-01) -
<i>BIRC5</i> Gene Polymorphisms Are Associated with a Higher Stage of Local and Regional Disease in Oral and Oropharyngeal Squamous Cell Carcinomas
by: Ivan Mumlek, et al.
Published: (2023-12-01) -
miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
by: Chao Yuan, et al.
Published: (2021-07-01) -
Bioinformatics analysis of laryngeal squamous cell carcinoma: seeking key candidate genes and pathways
by: Jinhua Ma, et al.
Published: (2021-04-01) -
Role and research progress of hematological markers in laryngeal squamous cell carcinoma
by: Hui Qi
Published: (2023-04-01)